Johnson & Johnson (JNJ) Other Non-Current Liabilities (2009 - 2026)

Johnson & Johnson has disclosed Other Non-Current Liabilities across 18 years of filings, most recently posting $486.0 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $486.0 million, down 60.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $486.0 million (down 60.52% YoY), and the FY2025 annual result was $486.0 million, down 60.07% from the prior year.
• Other Non-Current Liabilities came in at $486.0 million for Q1 2026 at Johnson & Johnson, roughly flat from $486.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $10.3 billion in Q2 2025 to a low of $486.0 million in Q2 2022.
• The 5-year median for Other Non-Current Liabilities is $1.1 billion (2023), against an average of $1.9 billion.
• Across the five-year window, Other Non-Current Liabilities jumped 722.36% in 2025 and sank 60.52% in 2026, its largest moves.
• Johnson & Johnson's Other Non-Current Liabilities stood at $525.0 million in 2022, then surged by 108.0% to $1.1 billion in 2023, then gained by 11.45% to $1.2 billion in 2024, then plunged by 60.07% to $486.0 million in 2025, then changed by 0.0% to $486.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $486.0 million (Q1 2026), $486.0 million (Q4 2025), and $9.9 billion (Q3 2025), per Business Quant data.